BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38184802)

  • 21. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prader-Willi Syndrome with Slowly Progressive Insulin-dependent Diabetes Mellitus.
    Tomoda Y; Okauchi Y; Deguchi A; Takenoshita Y; Iwahashi H; Mineo I
    Intern Med; 2021 May; 60(9):1423-1426. PubMed ID: 33250457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slowly progressive insulin-dependent diabetes mellitus associated with pernicious anemia.
    Kinoshita J; Hata S; Yamazaki H; Tajima N
    Intern Med; 2010; 49(2):155-9. PubMed ID: 20075581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM.
    Kobayashi T; Nishida Y; Tanaka S; Aida K
    Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of myasthenia gravis accompanied by large thymoma and anti-GAD antibody].
    Kitae S; Kawakami H; Matsuoka N; Etoh R; Nakamura S
    Rinsho Shinkeigaku; 2001 Nov; 41(11):818-21. PubMed ID: 12080617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
    Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
    J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).
    Awata T; Shimada A; Maruyama T; Oikawa Y; Yasukawa N; Kurihara S; Miyashita Y; Hatano M; Ikegami Y; Matsuda M; Niwa M; Kazama Y; Tanaka S; Kobayashi T
    Diabetes Ther; 2017 Oct; 8(5):1123-1134. PubMed ID: 28929327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction to New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
    J Diabetes Investig; 2024 May; 15(5):643. PubMed ID: 38534067
    [No Abstract]   [Full Text] [Related]  

  • 31. The over 50 year clinical course of a patient with slowly progressive type 1 diabetes (SPIDDM).
    Yanagisawa K; Omori Y; Fukushima S; Iwasaki N; Hashimoto N; Iwamoto Y
    Endocr J; 2010; 57(2):181-3. PubMed ID: 19952461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
    Xenou M; Zoupas I; Lygnos D; Fousteris E
    J Med Case Rep; 2022 Aug; 16(1):297. PubMed ID: 35918735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults.
    Sugiyama K; Saisho Y
    Diabetologia; 2022 Jan; 65(1):250-251. PubMed ID: 34766188
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Type 1 diabetes in the Japanese population the same as among Caucasians?
    Kawasaki E; Eguchi K
    Ann N Y Acad Sci; 2004 Dec; 1037():96-103. PubMed ID: 15699499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.
    Thomas NJ; Lynam AL; Hill AV; Weedon MN; Shields BM; Oram RA; McDonald TJ; Hattersley AT; Jones AG
    Diabetologia; 2019 Jul; 62(7):1167-1172. PubMed ID: 30969375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [letter].
    Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
    Diabetologia; 2022 Jan; 65(1):252-253. PubMed ID: 34762186
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
    Tanaka S; Okubo M; Nagasawa K; Takizawa S; Ichijo M; Ichijo S; Kaneshige M; Aida K; Shimura H; Mori Y; Kobayashi T
    Diabetol Int; 2016 Mar; 7(1):42-52. PubMed ID: 30603242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.
    Kawasaki E; Abiru N; Ide A; Sun F; Fukushima T; Takahashi R; Kuwahara H; Fujita N; Kita A; Oshima K; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
    Ann N Y Acad Sci; 2003 Nov; 1005():440-8. PubMed ID: 14679108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.
    Kobayashi M; Ohara N; Ikeda Y; Nagano O; Takada T; Kodama M; Sone H
    Intern Med; 2018 Dec; 57(24):3581-3587. PubMed ID: 30101912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
    Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.